UK MHRA Acts To Improve Quality Of GCP Serious Breach Reports
Patient Safety The Main Cause Of Notifications In 2019
The UK Medicines and Healthcare products Regulatory Agency has issued updated guidance and application form to help clinical trial sponsors provide better information on reports of serious breaches, which in turn would support the agency in assessing the issue.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.